Tango Therapeutics (TNGX) Other Working Capital Changes (2020 - 2025)
Historic Other Working Capital Changes for Tango Therapeutics (TNGX) over the last 6 years, with Q3 2025 value amounting to -$53.8 million.
- Tango Therapeutics' Other Working Capital Changes fell 36364.81% to -$53.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$66.5 million, marking a year-over-year decrease of 11257.87%. This contributed to the annual value of -$30.0 million for FY2024, which is 494.18% up from last year.
- Latest data reveals that Tango Therapeutics reported Other Working Capital Changes of -$53.8 million as of Q3 2025, which was down 36364.81% from -$3.2 million recorded in Q2 2025.
- In the past 5 years, Tango Therapeutics' Other Working Capital Changes ranged from a high of $16.4 million in Q2 2022 and a low of -$53.8 million during Q3 2025
- In the last 5 years, Tango Therapeutics' Other Working Capital Changes had a median value of -$5.4 million in 2025 and averaged -$8.0 million.
- As far as peak fluctuations go, Tango Therapeutics' Other Working Capital Changes skyrocketed by 164234.05% in 2021, and later plummeted by 216883.76% in 2022.
- Quarter analysis of 5 years shows Tango Therapeutics' Other Working Capital Changes stood at -$3.7 million in 2021, then decreased by 18.7% to -$4.4 million in 2022, then dropped by 23.12% to -$5.4 million in 2023, then grew by 24.19% to -$4.1 million in 2024, then tumbled by 1207.04% to -$53.8 million in 2025.
- Its Other Working Capital Changes stands at -$53.8 million for Q3 2025, versus -$3.2 million for Q2 2025 and -$5.4 million for Q1 2025.